| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | Chief Executive Officer
3 companies
Neupert Peter M serves as a Director at FTRE and has filed Form 4s across 3 companies. Across recent SEC filings that breaks down to 6 buys and 4 sells. Those positions are worth an estimated $826K at current prices.
Historically, Neupert Peter M's trades have earned a below-average insider score of 37/100 across 5 rated trades. Over a 12-month horizon, 0.0% of those trades were profitable, with an average 12-month return of -39.9%.
The biggest single holding is ADPT (~$826K) as Director. The recent filings there lean toward selling, a net 134,690 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 17, 2026 | ADPT Adaptive Biotechnologies Corporation | Director | Sale+OE | 124,690 | $25.15 | $3,135,850.40 | -48.8% | - | - | |
| Aug 11, 2025 | FTRE Fortrea Holdings Inc. | Director | Buy | 62,500 | $6.51 | $407,150.00 | +175.4% | +75.0% | +205.5% | |
| Mar 10, 2025 | ADPT Adaptive Biotechnologies Corp | Director | Sale+OE | 10,000 | $7.05 | $70,500.00 | -4.3% | +56.7% | +117.7% | |
| Aug 23, 2023 | FTRE Fortrea Holdings Inc. | Director | Buy | 11,000 | $25.30 | $278,256.00 | +100.0% | +28.7% | -15.6% | |
| Feb 16, 2022 | LH Labcorp Holdings Inc. | Director | Buy | 3,500 | $263.66 | $922,815.00 | +51.8% | -8.1% | -4.2% |